Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 15, 1999

Primary Completion Date

May 31, 2011

Study Completion Date

August 31, 2012

Conditions
Liver CancerMetastatic Cancer
Interventions
DRUG

cisplatin

Doxorubicin 30 mg, mitomycin 30 mg, and cisplatin 100 mg (all in powdered form) should be dissolved in 10-15 cc of contrast agent (such as isovue or optiray).

DRUG

doxorubicin

Doxorubicin 30 mg, mitomycin 30 mg, and cisplatin 100 mg (all in powdered form) should be dissolved in 10-15 cc of contrast agent (such as isovue or optiray).

DRUG

mitomycin

Doxorubicin 30 mg, mitomycin 30 mg, and cisplatin 100 mg (all in powdered form) should be dissolved in 10-15 cc of contrast agent (such as isovue or optiray).

PROCEDURE

embolization

Immediately following delivery of the chemoemulsion, particulate embolization is performed. The particulate embolic material is prepared on a separate table or tray, using absorbable gelatin sponge (Gelfoam, Upjohn, Kalamazoo, MI), in either powder or pledget form. Approximately 1 g of this temporary occlusive agent is dissolved in 20-30 cc of full-strength contrast with 2.4 cc of absolute alcohol.

Trial Locations (37)

19141

Albert Einstein Cancer Center, Philadelphia

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Winship Cancer Institute of Emory University, Atlanta

32207

Baptist Cancer Institute - Jacksonville, Jacksonville

44106

Case Comprehensive Cancer Center, Cleveland

45801

St. Rita's Medical Center, Lima

46360

Saint Anthony Memorial Health Centers, Michigan City

49001

Borgess Medical Center, Kalamazoo

49007

Bronson Methodist Hospital, Kalamazoo

50266

Medical Oncology and Hematology Associates - West Des Moines, West Des Moines

50307

Mercy Capitol Hospital, Des Moines

50309

CCOP - Iowa Oncology Research Association, Des Moines

John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines

Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines

50314

Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines

Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines

60048

North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville

60076

Hematology Oncology Associates - Skokie, Skokie

Hematology/Oncology of the North Shore at Gross Point Medical Center, Skokie

60432

Midwest Center for Hematology/Oncology, Joliet

60435

Joliet Oncology-Hematology Associates, Limited - West, Joliet

60507

Rush-Copley Cancer Care Center, Aurora

60521

Hinsdale Hematology Oncology Associates, Hinsdale

60611

Hematology and Oncology Associates, Chicago

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

60616

Mercy Hospital and Medical Center, Chicago

60625

Swedish Covenant Hospital, Chicago

61801

Carle Cancer Center at Carle Foundation Hospital, Urbana

CCOP - Carle Cancer Center, Urbana

80524

Front Range Cancer Specialists, Fort Collins

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

50316-2301

John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines

49007-3731

West Michigan Cancer Center, Kalamazoo

07962

Carol G. Simon Cancer Center at Morristown Memorial Hospital, Morristown

08876

Somerset Medical Center, Somerville

07902

Overlook Hospital, Summit

19111-2497

Fox Chase Cancer Center - Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK